Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma-Reference-Cited by-全球学者库

Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma

Published:2021-10-19 Issue:24 Volume:8 Page:2102051
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

Kong Huimin¹,Ju Enguo¹,Yi Ke¹,Xu Weiguo²,Lao Yeh‐Hsing³,Cheng Du⁴,Zhang Qi¹⁵,Tao Yu¹⁵,Li Mingqiang¹,Ding Jianxun²^ORCID

Affiliation:

1. Laboratory of Biomaterials and Translational Medicine Center for Nanomedicine and Biotherapy Center The Third Affiliated Hospital Sun Yat‐sen University 600 Tianhe Road Guangzhou 510630 P. R. China

2. Key Laboratory of Polymer Ecomaterials Changchun Institute of Applied Chemistry Chinese Academy of Sciences 5625 Renmin Street Changchun 130022 P. R. China

3. Department of Biomedical Engineering Columbia University 3960 Broadway Lasker Room 450 New York NY 10032 USA

4. PCFM Lab of Ministry of Education School of Materials Science and Engineering Sun Yat‐sen University 135 Xingangxi Road Guangzhou 510275 P. R. China

5. Guangdong Provincial Key Laboratory of Liver Disease Research 600 Tianhe Road Guangzhou 510630 P. R. China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Guangdong Provincial Pearl River Talents Program

Youth Innovation Promotion Association of the Chinese Academy of Sciences

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202102051

Reference232 articles.

1. Stem cell therapy and tissue engineering strategies using cell aggregates and decellularized scaffolds for the rescue of liver failure

2. Targeting Nestin+ hepatic stellate cells ameliorates liver fibrosis by facilitating TβRI degradation

3. Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform

4. Hepatocellular carcinoma

5. Challenges towards the realization of individualized cancer vaccines

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment;MedComm – Biomaterials and Applications;2024-01-14

2. Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma;Virology Journal;2024-01-12

3. CRISPR/Cas detection with nanodevices: moving deeper into liquid biopsy;Chemical Communications;2024

4. Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy;Advanced Materials;2023-12-12

5. Hepatocyte-confined CRISPR/Cas9-based nanocleaver precisely eliminates viral DNA for efficient and safe treatment of hepatitis B virus infection;Nano Today;2023-12